HCP, or Patient with a referral code?

Sign Up

BioCeuticals
Home
Chevron Icon Horizontal
education
Chevron Icon Horizontal
articles
Articles

Uncovering the hidden costs of migraines

BioCeuticals The hidden cost of migraine Header.png

Table of Contents

  1. Migraine prevalence
  2. Difficulty in managing migraine
  3. Migraine types
  4. Migraine treatment options
  5. Research highlight:
  6. Clinical insight:
  7. Summary

Migraine prevalence

Migraine affects 4.9 million Australians1 and at least 12% of the global population2 with migraine incidence increasing by over two per cent between 1990 and 2019.

Key highlights

  • Migraine requires individualised management.
  • Varying subtypes of migraine may complicate treatment and can impact clinical decision-making.
  • Research supports a number of complementary medicines for the management of migraine with new research showing benefits for vestibular migraine in particular.
  • Migraine that is not managed or prevented by pharmacological approaches is considered refractory.
  • Medication-overuse headache is a secondary disorder caused by excessive use of acute medications.